Clinical relevance and characteristics of pleural effusion in patients with Mycoplasma pneumoniae pneumonia

Scandinavian Journal of Infectious Diseases

Volumn 44, Issue 10, 2012, Pages 793-797

  Cha, Seung Ick ^a   Shin, Kyung Min ^a   Jeon, Kyung Nyeo ^b   Yoo, Seung Soo ^a   Lee, Jaehee ^a   Lee, Shin Yup ^a   Kim, Chang Ho ^a   Park, Jae Yong ^a   Jung, Tae Hoon ^a  

^a Kyungpook National University School of Medicine   (South Korea)

^b Gyeongsang National University School of Medicine   (South Korea)

Author keywords

Mycoplasma pneumoniae; Pleural effusion; Pneumonia

Indexed keywords

ADENOSINE DEAMINASE; CORTICOSTEROID; LACTATE DEHYDROGENASE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME BLOOD LEVEL; FEMALE; HOSPITALIZATION; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOCYTE COUNT; LYMPHOCYTE; MALE; MYCOPLASMA PNEUMONIA; NEUTROPHIL; PLEURA EFFUSION; PLEURA FLUID;

ADOLESCENT; ADULT; EXUDATES AND TRANSUDATES; FEMALE; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; MYCOPLASMA PNEUMONIAE; PLEURAL EFFUSION; PNEUMONIA, MYCOPLASMA; YOUNG ADULT;

EID: 84866649698     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2012.681696     Document Type: Article

References (22)

1. Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, et al. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med 2007;175:1086-93.
2. Wang RS, Wang SY, Hsieh KS, Chiou YH, Huang IF, Cheng MF, et al. Necrotizing pneumonitis caused by Mycoplasma pneumoniae in pediatric patients: report of fi ve cases and review of literature. Pediatr Infect Dis J 2004;23:564-7.
3. Okada F, Ando Y, Wakisaka M, Matsumoto S, Mori H. Chlamydia pneumoniae pneumonia and Mycoplasma pneu-moniae pneumonia: comparison of clinical fi ndings and CT fi ndings. J Comput Assist Tomogr 2005;29:626-32.
4. Nambu A, Saito A, Araki T, Ozawa K, Hiejima Y, Akao M, et al. Chlamydia pneumoniae: comparison with fi ndings of Mycoplasma pneumoniae and Streptococcus pneumoniae at thin-section CT. Radiology 2006;238:330-8.
5. Reittner P, Muller NL, Heyneman L, Johkoh T, Park JS, Lee KS, et al. Mycoplasma pneumoniae pneumonia: radiographic and high-resolution CT features in 28 patients. Am J Roent-genol 2000;174:37-41.
6. Miyashita N, Sugiu T, Kawai Y, Oda K, Yamaguchi T, Ouchi K, et al. Radiographic features of Mycoplasma pneumoniae pneumonia: differential diagnosis and performance timing. BMC Med Imaging 2009;9:7.
7. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997;336:243-50.
8. Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003;58:377-82.
9. Barker CE, Sillis M, Wreghitt TG. Evaluation of Serodia Myco II particle agglutination test for detecting Mycoplasma pneu-moniae antibody: comparison with mu-capture ELISA and indirect immunofl uorescence. J Clin Pathol 1990;43:163-5.
10. Daxboeck F, Krause R, Wenisch C. Laboratory diagnosis of Mycoplasma pneumoniae infection. Clin Microbiol Infect 2003;9:263-73.
11. Luo YF, Robbins IM, Karatas M, Brixey AG, Rice TW, Light RW. Frequency of pleural effusions in patients with pulmonary arterial hypertension associated with connective tissue diseases. Chest 2011;140:42-7.
12. rd ed. Academic Press; 1983 pp 315-23.
13. Pauls S, Kruger S, Muche R, Klemen D, Billich C, Gerstner S, et al. Assessment of pneumonia severity: multidetector-row CT in comparison to clinical score CRB-65. Clin Imaging 2008;32:342-5.
14. Lee I, Kim TS, Yoon HK. Mycoplasma pneumoniae pneumonia: CT features in 16 patients. Eur Radiol 2006;16:719-25.
15. Tanaka H, Koba H, Honma S, Sugaya F, Abe S. Relationships between radiological pattern and cell-mediated immune response in Mycoplasma pneumoniae pneumonia. Eur Respir J 1996;9:669-72.
16. Rollins S, Colby T, Clayton F. Open lung biopsy in Myco-plasma pneumoniae pneumonia. Arch Pathol Lab Med 1986; 110:34-41.
17. Sahn SA. State of the art. The pleura. Am Rev Respir Dis 1988;138:184-234.
18. Perez-Rodriguez E, Castro DJ. The use of adenosine deam-inase and adenosine deaminase isoenzymes in the diagnosis of tuberculous pleuritis. Curr Opin Pulm Med 2000;6: 259-66.
19. Greco S, Girardi E, Masciangelo R, Capoccetta GB, Saltini C. Adenosine deaminase and interferon gamma measurements for the diagnosis of tuberculous pleurisy: a meta-analysis. Int J Tuberc Lung Dis 2003;7:777-86.
20. Krenke R, Korczynski P. Use of pleural fl uid levels of adenosine deaminase and interferon gamma in the diagnosis of tuberculous pleuritis. Curr Opin Pulm Med 2010;16: 367-75.
21. Gakis C. Adenosine deaminase (ADA) isoenzymes ADA1 and ADA2: diagnostic and biological role. Eur Respir J 1996; 9:632-3.
22. Trajman A, Pai M, Dheda K, van Zyl Smit R, Swerling AA, Joshi R, et al. Novel tests for diagnosing tuberculous pleural effusion: what works and what does not? Eur Respir J 2008;31:1098-106.